Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
Hoskin, K L
Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. [electronic resource] - Experimental neurology Mar 1998 - 45-51 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0014-4886
10.1006/exnr.1997.6749 doi
Animals
Cats
Cerebrovascular Circulation--drug effects
Cranial Sinuses
Electric Stimulation
Gene Expression Regulation--drug effects
Genes, fos
Migraine Disorders--drug therapy
Neurons, Afferent--drug effects
Nociceptors--drug effects
Oxazoles--pharmacology
Oxazolidinones
Pain--physiopathology
Receptor, Serotonin, 5-HT1B
Receptor, Serotonin, 5-HT1D
Receptors, Serotonin--drug effects
Serotonin Receptor Agonists--pharmacology
Sumatriptan--pharmacology
Synaptic Transmission--drug effects
Trigeminal Caudal Nucleus--physiopathology
Trigeminal Nerve--drug effects
Trigeminal Nucleus, Spinal--physiopathology
Tryptamines
Vasoconstrictor Agents--pharmacology
Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. [electronic resource] - Experimental neurology Mar 1998 - 45-51 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0014-4886
10.1006/exnr.1997.6749 doi
Animals
Cats
Cerebrovascular Circulation--drug effects
Cranial Sinuses
Electric Stimulation
Gene Expression Regulation--drug effects
Genes, fos
Migraine Disorders--drug therapy
Neurons, Afferent--drug effects
Nociceptors--drug effects
Oxazoles--pharmacology
Oxazolidinones
Pain--physiopathology
Receptor, Serotonin, 5-HT1B
Receptor, Serotonin, 5-HT1D
Receptors, Serotonin--drug effects
Serotonin Receptor Agonists--pharmacology
Sumatriptan--pharmacology
Synaptic Transmission--drug effects
Trigeminal Caudal Nucleus--physiopathology
Trigeminal Nerve--drug effects
Trigeminal Nucleus, Spinal--physiopathology
Tryptamines
Vasoconstrictor Agents--pharmacology